Furthermore, and contrary to the common belief that chemotherapeutic agents only act through direct killing of tumor cells, our data shows that FOLFOX distinctively modulates CD8 anti-tumor immunity to reduce tumor burden. The gene discussed is CD8A; the disease is neoplasm.